Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Radiology
Volume 2013 (2013), Article ID 214804, 4 pages
http://dx.doi.org/10.1155/2013/214804
Case Report

Pharmacomechanical Thrombolysis in the Management of Paget-Schroetter Syndrome

Multidisciplinary Endovascular Team, University College London Hospitals, 235 Euston Road, London NW1 2BU, UK

Received 2 December 2012; Accepted 16 January 2013

Academic Editors: R. Dammers and O. Strohm

Copyright © 2013 Elli Papantoniou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Paget-Schroetter syndrome (PSS) is a rare form of thoracic outlet syndrome caused by axillosubclavian vein thrombosis which typically presents in healthy young adults. Prompt therapy, traditionally by means of catheter-directed thrombolysis (CDT) prior to definitive surgery, can prevent the subsequent onset of postthrombotic syndrome (PTS) and considerable disability. As CDT is associated with major haemorrhage and high overall treatment cost, pharmacomechanical thrombectomy (PMT) seems to be an attractive alternative which combines pharmacological thrombolysis with mechanical clot disruption. The Trellis-8 peripheral infusion catheter is an example of such a treatment which provides topical thrombolysis in an isolated zone. We describe the use of the Trellis-8 PMT system in the successful management of three patients with PSS.